Tech Company Financing Transactions

Magenta Therapeutics Funding Round

On 5/3/2017, Magenta Therapeutics raised $50 million in Series B funding from GV, Access Industries and Atlas Accelerator.

Transaction Overview

Announced On
5/3/2017
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series B
Proceeds Purpose
The financing announced today is intended to fuel development of innovative product candidates across multiple aspects of transplantation medicine, including more precise preparation of patients, stem cell harvesting and stem cell expansion.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Technology Sq. 5th Floor
Cambridge, MA 02139
USA
Email Address
Overview
Magenta Therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases.
Profile
Magenta Therapeutics LinkedIn Company Profile
Social Media
Magenta Therapeutics Company Twitter Account
Company News
Magenta Therapeutics News
Facebook
Magenta Therapeutics on Facebook
YouTube
Magenta Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jason Gardner
  Jason Gardner LinkedIn Profile  Jason Gardner Twitter Account  Jason Gardner News  Jason Gardner on Facebook
Chief Medical Officer
John Davis
  John Davis LinkedIn Profile  John Davis Twitter Account  John Davis News  John Davis on Facebook
Chief Operating Officer
Jason Ryan
  Jason Ryan LinkedIn Profile  Jason Ryan Twitter Account  Jason Ryan News  Jason Ryan on Facebook
Vice President
Manisha Pai
  Manisha Pai LinkedIn Profile  Manisha Pai Twitter Account  Manisha Pai News  Manisha Pai on Facebook
VP - Bus. Development
Christina Isacson
  Christina Isacson LinkedIn Profile  Christina Isacson Twitter Account  Christina Isacson News  Christina Isacson on Facebook
VP - General Counsel
Zoran Zdraveski
  Zoran Zdraveski LinkedIn Profile  Zoran Zdraveski Twitter Account  Zoran Zdraveski News  Zoran Zdraveski on Facebook
VP - Human Resources
Kristen Stants
  Kristen Stants LinkedIn Profile  Kristen Stants Twitter Account  Kristen Stants News  Kristen Stants on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/3/2017: Cocrystal Discovery venture capital transaction
Next: 5/3/2017: Iconixx venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to record every notable VC transaction. VC investment data records on this site come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary